Joel M. Friedman

Adhesives Research, Inc. provides adhesive-coated materials. It offers pressure-sensitive adhesives for applications in mobile devices, hard disk drives, touch screens and displays, semiconductors, photovoltaic bonding, and medical electronic systems; engineered tapes for industrial bonding and assembly, window fabrication, and solar PV applications; and splicing products for pulp and paper, laminating, converting and flexible packaging. The company was founded in 1961 and is headquartered in Glen Rock, PA.

DermTech Operations, Inc. engages in the provision of molecular dermatology. It develops products that facilitate the early detection of skin cancers, assess inflammatory diseases, and customize drug treatments. The firm's products include adhesive skin collection kit, pigmented lesion assay (PLA), nevome, inflammatory disease and carcinome. The company was founded by Lawrence A. Rheins in 1996 and is headquartered in La Jolla, CA.

Vaxiion Therapeutics, Inc. operates as a biotechnology company. Its nanodelivery platforms are based on genetically engineered, non-living bacterial minicells that are capable of packaging, targeting and delivering a wide array of therapeutically relevant molecules (including protein toxins, small molecule drugs, RNAi, plasmids, peptides and imaging agents) directly to cancer cells. The company was founded by Roger Allen Sabbadini, Neil L. Berkley and William Gerhart in 2000 and is headquartered in San Diego, CA.

Western States Investment Corp ( Western States Investment ) is a private equity firm founded in 1976. The firm is headquartered in San Diego, California.

Part of Clayton, Dubilier & Rice Holdings LP, National Sanitary Supply Co. is an American company that distributes sanitary supplies. The company is based in OH. National Sanitary Supply was acquired by Unisource Worldwide, Inc. from Chemed Corp. on October 01, 1997 for $131.67 million.

MPEX Pharmaceuticals, Inc. develops and manufactures therapies for antibiotic resistance with focus on gram-negative organisms. It offers Aeroquin (MP- 376), an aerosol formulation of levofloxacin for the treatment of pulmonary infections in patients with cystic fibrosis, as well as antibiotic programs to address antibiotic resistance in gram negative organisms. The company was founded in 2001 and is headquartered in San Diego, CA.